Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schlenk, Richard
309  Ergebnisse:
Personensuche X
?
1

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Harrison, Claire ; Mascarenhas, John ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e87048d4 , 2023
Link: https://doi.org/10.1097/..
 
?
2

Real‐world data for precision cancer medicine—A European pe..:

Christopoulos, Petros ; Schlenk, Richard ; Kazdal, Daniel...
Genes, Chromosomes and Cancer.  62 (2023)  9 - p. 557-563 , 2023
Link: https://doi.org/10.1002/..
 
?
3

PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WI..:

Kayser, Sabine ; Sanber, Khaled ; Marconi, Giovanni...
HemaSphere.  7 (2023)  S3 - p. e1610525 , 2023
Link: https://doi.org/10.1097/..
 
?
4

Overlapping features of therapy-related and de novo NPM1-mu..:

Othman, Jad ; Meggendorfer, Manja ; Tiacci, Enrico...
Blood.  141 (2023)  15 - p. 1846-1857 , 2023
Link: https://doi.org/10.1182/..
 
?
5

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETI..:

Kayser, Sabine ; Sartor, Chiara ; Giglio, Fabio...
HemaSphere.  7 (2023)  S3 - p. e9701805 , 2023
Link: https://doi.org/10.1097/..
 
?
6

S137: IMPACT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATI..:

Schlenk, Richard ; Montesinos, Pau ; Romero-Aguilar, Antonio...
HemaSphere.  7 (2023)  S3 - p. e61150fb , 2023
Link: https://doi.org/10.1097/..
 
?
7

P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY M..:

Roehnert, Maximilian ; Kramer, Michael ; Schadt, Jonas...
HemaSphere.  7 (2023)  S3 - p. e175805c , 2023
Link: https://doi.org/10.1097/..
 
?
8

Characterizing the Next Generation of Neurosurgeons: A Desc..:

Winkelman, Robert D. ; Palmer, Peter ; Lilly, Daniel...
World Neurosurgery.  173 (2023)  - p. e76-e80 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Midostaurin in addition to intensive chemotherapy in acute ..:

Ruhnke, Leo ; Röllig, Christoph ; Herold, Sylvia...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
10

Poster: AML-029 Quizartinib Prolonged Overall Survival (OS)..:

Erba, Harry ; Montesinos, Pau ; Vrhovac, Radovan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S124 , 2022
Link: https://doi.org/10.1016/..
 
?
11

AML-029 Quizartinib Prolonged Overall Survival (OS) vs Plac..:

Erba, Harry ; Montesinos, Pau ; Vrhovac, Radovan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S208-S209 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Multidisciplinary Approach to Isolated Pulmonary Vein Compr..:

Kindzelski, Bogdan A. ; Ghobrial, Joanna ; Schlenk, Richard..
JACC: Case Reports.  4 (2022)  3 - p. 145-149 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Community-driven development of a modified progression-free..:

Mock, Andreas ; Heilig, Christoph E ; Kreutzfeldt, Simon...
ESMO Open.  4 (2019)  6 - p. e000583 , 2019
Link: https://doi.org/10.1136/..
 
?
14

3. Krankheitsspezifische Therapieoptionen bei myeloischen N..:

, In: Myeloische Neoplasien,
Nolte, Florian ; Schlenk, Richard ; Schwaab, Juliana... - p. 131-244 , 2019
Link: https://doi.org/10.1515/..
 
?
15

The Role of Laboratory Dissection Training in Neurosurgical..:

Kshettry, Varun R. ; Mullin, Jeffrey P. ; Schlenk, Richard..
World Neurosurgery.  82 (2014)  5 - p. 554-559 , 2014
Link: https://doi.org/10.1016/..
 
1-15